Paper100810
The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.
Sørensen B and 3 others. Psychopharmacology (Berl), 1978. Cited by 37 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression. Papers, record 100810. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/100810
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The practical significance of nortriptyline plasma control. A prospective evaluation under routine conditions in endogenous depression.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Depression | Major topic |
| Nortriptyline | Major topic |
| Aged | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,824,200 | The efficacy of antidepressant drugs. A review of research (1958-1972). | Arch Gen Psychiatry | 1974 | https://conductscience.org/library/papers/4824200 | PubMed |
| 2 | 4,118,463 | Plasma-nortriptyline levels in endogenous depression. | Lancet | 1973 | https://conductscience.org/library/papers/4118463 | PubMed |
| 3 | 981,330 | Therapeutic control of plasma concentrations and long-term effect of nortriptyline in recurrent affective disorders. | Pharmakopsychiatr Neuropsychopharmakol | 1976 | https://conductscience.org/library/papers/981330 | PubMed |
| 4 | 766,041 | Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression. | Psychopharmacologia | 1976 | https://conductscience.org/library/papers/766041 | PubMed |
| 5 | 4,208,380 | Long-term treatment of endogenous depression with nortriptyline with control of plasma levels. | Psychol Med | 1974 | https://conductscience.org/library/papers/4208380 | PubMed |
| 6 | 871,827 | Routine nortriptyline levels in treatment of depression. | Br Med J | 1977 | https://conductscience.org/library/papers/871827 | PubMed |
| 7 | 4,950,568 | A pharmacokinetic approach to the treatment of depression. | Int Pharmacopsychiatry | 1971 | https://conductscience.org/library/papers/4950568 | PubMed |
| 8 | 860,894 | A comparison study of amitriptyline and nortriptyline with plasma levels. | Arch Gen Psychiatry | 1977 | https://conductscience.org/library/papers/860894 | PubMed |
| 9 | 4,762,222 | International reliability and communicability of a rating scale for depression. | Psychol Med | 1973 | https://conductscience.org/library/papers/4762222 | PubMed |
| 10 | 869,057 | Relationship between age and tricyclic antidepressant plasma levels. | Am J Psychiatry | 1977 | https://conductscience.org/library/papers/869057 | PubMed |
| 11 | 788,992 | Nortriptyline plasma levels and therapeutic response. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/788992 | PubMed |
| 12 | 5,558,186 | Relationship between plasma level and therapeutic effect of nortriptyline. | Br Med J | 1971 | https://conductscience.org/library/papers/5558186 | PubMed |
| 13 | 10,583 | Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects. | Pharmakopsychiatr Neuropsychopharmakol | 1976 | https://conductscience.org/library/papers/10583 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,849,844 | Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP-432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects. | CNS Neurosci Ther | 2016 | https://conductscience.org/library/papers/26849844 | PubMed |
| 19,277,699 | Trifluoperazine: a rynodine receptor agonist. | Pflugers Arch | 2009 | https://conductscience.org/library/papers/19277699 | PubMed |
| 6,812,139 | Amitriptyline and nortriptyline response profiles in unipolar depressed patients. | Psychopharmacology (Berl) | 1982 | https://conductscience.org/library/papers/6812139 | PubMed |
| 6,499,343 | Prediction of steady-state nortriptyline plasma levels by the repeated one-point method. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6499343 | PubMed |
| 6,412,270 | The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients. | Psychopharmacology (Berl) | 1983 | https://conductscience.org/library/papers/6412270 | PubMed |
| 6,114,851 | Current antidepressant drugs: their clinical use. | Drugs | 1981 | https://conductscience.org/library/papers/6114851 | PubMed |
| 42,101 | Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response. | Psychopharmacology (Berl) | 1979 | https://conductscience.org/library/papers/42101 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/100810
GET https://conductscience.org/api/papers/v1/100810/authors